Delivery Order SPE2DB24D2217-SPE2DB25FJWEF

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,467.91 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,851.81 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.06 Firm Fixed Price Delivery Order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,525.20, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.87 firm fixed-price delivery order is for ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through February 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,523.80 firm fixed-price delivery order is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of November 21, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,459.86 firm fixed-price delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,675.76, is a delivery order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,114.17 firm fixed-price delivery order contract covers the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,774.99, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The award has an ultimate completion date of April 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB25FJWEF
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,386.65 firm fixed-price delivery order contract covers the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has no set-aside designation, indicating open competition.

Generated 4/22/25, 11:48 AM